Cheryl Cox, MHA, MT (ASCP)

Cheryl Cox, MHA, MT (ASCP) Operations Director, Cell Therapies Facility

Cheryl Cox is the Operations Director of Cell Therapies and Gene Engineering Facility at the Moffitt Cancer in Tampa, Florida. Cheryl has provided leadership for cellular therapy facilities for over nine years.

She attended the University of Evansville receiving a degree in Clinical Laboratory Sciences and has a master’s in health administration. She is board certified by the American Society of Clinical Pathology as a Medical Technologist Generalist and Supervisor.

Cheryl started her career in cardiovascular research at Bristol Myers Squibb. She eventually transferred to Immunology research at BMS. During subsequent years, Cheryl worked at a clinical research organization,  a cord blood biotech, a viral vector facility, a cord blood bank, and in correlative studies before moving to Moffitt.  Cheryl has over 20 years of management experience with 12 years in cGMP programs.

At Moffitt, Cheryl has worked on the production of various cellular therapy clinical trial products, overseen BMT Standard of Care, and the implementation of commercial FDA-approved products.  She has spearheaded new departmental protocols and procedures to achieve compliance with regulatory requirements. Additionally, Cheryl plans and monitors the day-to-day running of the business to facilitate smooth progress while working with superiors to make decisions for operational activities and set strategic goals.

Cheryl is an approved FACT auditor, a Lab committee member of ISCT and an active member of AABB.